Purpose: Individualized selection of patients with early-stage hormone receptor–positive
(HR+) breast cancer for extended endocrine therapy (EET) is required to balance modest …

Importance There is a need for biomarkers that predict late recurrence risk and extended
endocrine therapy (EET) benefit among patients with early-stage breast cancer (EBC) …

PURPOSE Most distant recurrences (DRs) in women with hormone receptor–positive breast
cancer occur after 5 years from diagnosis. The Clinical Treatment Score post-5 years (CTS5) …

Background While adjuvant endocrine therapy (AET) for early-stage, hormone-sensitive
breast cancer confers a 40–50% reduction in recurrence risk, adherence to AET is …

Introduction Studies investigating the long-term effects of breast cancer treatment on
cognition in older women with breast cancer are lacking, even though preserving cognition …

Background Daily adjuvant endocrine therapy (AET) for 5 or 10 years is the standard of care
for women diagnosed with non-metastatic hormone receptor-positive breast cancer …

A distonia é caracterizada por contrações musculares involuntárias, sustentadas ou
intermitentes, responsáveis por movimentos e posturas anormais. Trata-se de um distúrbio …

Ein signifikanter Einfluss von körperlicher Aktivität auf Lebensqualität, körperliche und
berufliche Leistung, Schmerzen, Fatigue und eine Zunahme des Appetits konnte gezeigt …

Purpose Regular primary care may be important to prevent ambulatory care-sensitive
hospitalizations among older individuals living with breast cancer. The current study aimed …

Purpose: Individualized selection of patients with early-stage hormone receptor-positive
(HR+) breast cancer for extended endocrine therapy (EET) is required to balance modest …